4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-22-014695
Chief Financial Officer bought 39,000 shares at an average $0.29 ($11,161)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hunt Jonathan Robert Chief Financial Officer | 2022-06-07 | Purchase | +13,325 | $0.28 | $3,718 | 80,631 | D |
| Hunt Jonathan Robert Chief Financial Officer | 2022-06-08 | Purchase | +25,675 | $0.29 | $7,443 | 106,306 | D |
| Open-market purchases · 39,000 sh · avg $0.29 · $11,161 | |||||||
Loading xslF345X03/rdgdoc.xml…